These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 37982419

  • 1. Deciphering the DNA methylome in women with PCOS diagnosed using the new international evidence-based guidelines.
    Wang Y, Gao X, Yang Z, Yan X, He X, Guo T, Zhao S, Zhao H, Chen ZJ.
    Hum Reprod; 2023 Nov 20; 38(Supplement_2):ii69-ii79. PubMed ID: 37982419
    [Abstract] [Full Text] [Related]

  • 2. Evidence of positive selection of genetic variants associated with PCOS.
    Yu Z, Li Y, Zhao S, Liu F, Zhao H, Chen ZJ.
    Hum Reprod; 2023 Nov 20; 38(Supplement_2):ii57-ii68. PubMed ID: 37982420
    [Abstract] [Full Text] [Related]

  • 3. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L, Li G, Zhong W, Bian Y, Su S, Sheng Y, Shi Y, Wei D, Zhang W, Zhao H, Chen ZJ.
    Hum Reprod; 2015 Mar 20; 30(3):732-6. PubMed ID: 25586784
    [Abstract] [Full Text] [Related]

  • 4. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ, Islam RM, Skiba MA, Herbert D, Martinez Garcia A, Davis SR.
    Hum Reprod; 2021 Dec 27; 37(1):109-118. PubMed ID: 34741176
    [Abstract] [Full Text] [Related]

  • 5. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 6. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ, Hwang KR, Chae SJ, Yoon SH, Choi YM.
    Hum Reprod; 2020 Mar 27; 35(3):652-659. PubMed ID: 32211797
    [Abstract] [Full Text] [Related]

  • 7. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
    Kim JJ, Hwang KR, Lee D, Kim S, Choi YM.
    Hum Reprod; 2024 May 02; 39(5):1072-1077. PubMed ID: 38514450
    [Abstract] [Full Text] [Related]

  • 8. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D, Alebić MŠ, Duhamel A, Stojanović N.
    Hum Reprod; 2014 Nov 02; 29(11):2536-43. PubMed ID: 25267785
    [Abstract] [Full Text] [Related]

  • 9. Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response.
    Cozzolino M, Herraiz S, Titus S, Roberts L, Romeu M, Peinado I, Scott RT, Pellicer A, Seli E.
    Hum Reprod; 2022 May 30; 37(6):1274-1286. PubMed ID: 35451009
    [Abstract] [Full Text] [Related]

  • 10. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 11. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE.
    J Clin Endocrinol Metab; 2023 Sep 18; 108(10):2447-2469. PubMed ID: 37580314
    [Abstract] [Full Text] [Related]

  • 12. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB, Vanky E, Carlsen SM.
    Hum Reprod; 2012 Aug 18; 27(8):2494-502. PubMed ID: 22693172
    [Abstract] [Full Text] [Related]

  • 13. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA, Bell RJ, Herbert D, Garcia AM, Islam RM, Davis SR.
    Hum Reprod; 2021 May 17; 36(6):1611-1620. PubMed ID: 33846715
    [Abstract] [Full Text] [Related]

  • 14. Transmission of polycystic ovary syndrome susceptibility single-nucleotide polymorphisms and their association with phenotype changes in offspring.
    Li J, Cui L, Jiang X, Zhao H, Zhao S, Shi Y, Wei D, You L, Ma J, Chen ZJ.
    Hum Reprod; 2020 Jul 01; 35(7):1711-1718. PubMed ID: 32619219
    [Abstract] [Full Text] [Related]

  • 15. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR.
    Hum Reprod; 2013 May 01; 28(5):1361-8. PubMed ID: 23503943
    [Abstract] [Full Text] [Related]

  • 16. 3 CpG Methylation Biomarkers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Blood Samples.
    Xie L, Jiang X, Chen Y, Huang C, Chen Y, Liu G, Sun W, Zeng L, Lu R.
    Comb Chem High Throughput Screen; 2022 May 01; 25(8):1304-1313. PubMed ID: 34080962
    [Abstract] [Full Text] [Related]

  • 17. Elevation of markers of endotoxemia in women with polycystic ovary syndrome.
    Banaszewska B, Siakowska M, Chudzicka-Strugala I, Chang RJ, Pawelczyk L, Zwozdziak B, Spaczynski R, Duleba AJ.
    Hum Reprod; 2020 Oct 01; 35(10):2303-2311. PubMed ID: 32869098
    [Abstract] [Full Text] [Related]

  • 18. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
    Wu T, Gao YY, Tang XN, Li Y, Dai J, Zhou S, Wu M, Zhang JJ, Wang SX.
    Hum Reprod; 2022 Nov 24; 37(12):2856-2866. PubMed ID: 36223608
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr 24; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 20. Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study.
    Yang Q, Zhao Y, Qiu X, Zhang C, Li R, Qiao J.
    Hum Reprod; 2015 Aug 24; 30(8):1964-73. PubMed ID: 26040477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.